{{Rsnum
|rsid=12927155
|Gene=FTO
|Chromosome=16
|position=54099888
|Orientation=plus
|GMAF=0.1465
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=FTO
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 69.0 | 25.7 | 5.3
| HCB | 73.0 | 24.8 | 2.2
| JPT | 70.8 | 27.4 | 1.8
| YRI | 83.6 | 15.8 | 0.7
| ASW | 82.1 | 17.9 | 0.0
| CHB | 73.0 | 24.8 | 2.2
| CHD | 76.1 | 20.2 | 3.7
| GIH | 84.0 | 16.0 | 0.0
| LWK | 86.4 | 13.6 | 0.0
| MEX | 63.8 | 32.8 | 3.4
| MKK | 92.1 | 7.9 | 0.0
| TSI | 69.6 | 30.4 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=20647405
|Title=No Association between FTO or HHEX and Endometrial Cancer Risk
|OA=1
}}

{{on chip | Affy GenomeWide 6}}